Keywords
Rat liver enzyme
MAO isoform
Selectivity
Inhibitors
How to Cite
Abstract
A series of carboxylates of pyrazolines (3a-3h) were synthesized from ethyl 2-benzylidene-3-oxobutanoate esters using hydrazine hydrate and ethanol as solvent. All the compounds (3a-3h) screened for their MAO inhibitory activity using rat brain MAO. All the compounds were found to be selective, reversible and competitive inhibitors of MAO-B except compound 3d and 3h which was found to be non-selective. These compounds were found to be active against MAO-B at concentration close to 1 ?M (3e = 0.99 ?M, 3a = 0.92 ?M and 3b = 1.11?M). Compound 3a was potent amongst these while 3b was more selective towards MAO-B with selectivity index 2.88.
References
Tipton, K. F.; Boyce, S.; O'Sullivan, J.; Davey, G. P.; Healy, J., Monoamine oxidases: certainties and uncertainties. Curr Med Chem 2004, 11, 1965-1982.
http://dx.doi.org/10.2174/0929867043364810
Slotkin, T. A., Mary Bernheim and the discovery of monoamine oxidase. Brain Res bull 1999, 50, 373.
http://dx.doi.org/10.1016/S0361-9230(99)00110-0
Hare, M. L. C., Tyramine oxidase: A new enzyme system in liver. Biochem J 1928, 22, 968.
Bach, A.; Lan, N. C.; Johnson, D. L.; Abell, C. W.; Bembenek, M. E.; Kwan, S.-W.; Seeburg, P. H.; Shih, J. C., cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci 1988, 85, 4934-4938.
http://dx.doi.org/10.1073/pnas.85.13.4934
Collins, G.; Sandler, M.; Williams, E.; Youdim, M., Multiple forms of human brain mitochondrial monoamine oxidase. Nature 1970, 225, 817-820.
http://dx.doi.org/10.1038/225817a0
Youdim, M.; Collins, G.; Sandler, M.; Jones, A. B.; Pare, C.; Nicholson, W., Biological Sciences: Human brain monoamine oxidase: Multiple forms and selective inhibitors. Nature 1972, 236, 225-228.
http://dx.doi.org/10.1038/236225b0
Johnston, J., Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 1968, 17, 1285-1297.
http://dx.doi.org/10.1016/0006-2952(68)90066-X
Knoll, J.; Magyar, K., Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 1971, 5, 393-408.
Kalgutkar, A. S.; Castagnoli, N.; Testa, B., Selective inhibitors of monoamine oxidase (MAO?A and MAO?B) as probes of its catalytic site and mechanism. Med Res Rev 1995, 15, 325-388.
http://dx.doi.org/10.1002/med.2610150406
Pacher, P.; Kohegyi, E.; Kecskemeti, V.; Furst, S., Current trends in the development of new antidepressants. Curr Med Chem 2001, 8, 89-100.
http://dx.doi.org/10.2174/0929867013373796
Pacher, P.; Kecskemeti, V., Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Curr Med Chem 2004, 11, 925.
http://dx.doi.org/10.2174/0929867043455594
Carreiras, M.; Marco, J., Recent approaches to novel anti-Alzheimer therapy. Curr Pharm Design 2004, 10, 3167-3176.
http://dx.doi.org/10.2174/1381612043383421
Chimenti, F.; Bolasco, A.; Manna, F.; Secci, D.; Chimenti, P.; Befani, O.; Turini, P.; Giovannini, V.; Mondov, B.; Cirilli, R., Synthesis and selective inhibitory activity of 1-acetyl-3, 5-diphenyl-4, 5-dihydro-(1 H)-pyrazole derivatives against monoamine oxidase. J Med Chem 2004, 47, 2071-2074.
http://dx.doi.org/10.1021/jm031042b
Chimenti, F.; Maccioni, E.; Secci, D.; Bolasco, A.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Alcaro, S.; Ortuso, F., Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3, 5-diaryl-4, 5-dihydro-(1 H)-pyrazole derivatives. J Med Chem 2005, 48, 7113-7122.
http://dx.doi.org/10.1021/jm040903t
Secci, D.; Bolasco, A.; Chimenti, P.; Carradori, S., The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents. Curr Med Chem 2011, 18, 5114-5144.
http://dx.doi.org/10.2174/092986711797636090
Khalil, N. A.; Ahmed, E. M.; El-Nassan, H. B.; Ahmed, O. K.; Al-Abd, A. M., Synthesis and biological evaluation of novel pyrazoline derivatives as anti-inflammatory and antioxidant agents. Arch Pharm Res 2012, 35, 995-1002.
http://dx.doi.org/10.1007/s12272-012-0606-9
Azarifar, D.; Shaebanzadeh, M., Synthesis and characterization of new 3, 5-dinaphthyl substituted 2-pyrazolines and study of their antimicrobial activity. Molecules 2002, 7, 885-895.
http://dx.doi.org/10.3390/71200885
Ali, M. A.; Yar, M. S.; Kumar, M.; Pandian, G. S., Synthesis and antitubercular activity of substituted novel pyrazoline derivatives. Nat Prod Res 2007, 21, 575-579.
http://dx.doi.org/10.1080/14786410701369367
Puig-Basagoiti, F.; Tilgner, M.; Forshey, B. M.; Philpott, S. M.; Espina, N. G.; Wentworth, D. E.; Goebel, S. J.; Masters, P. S.; Falgout, B.; Ren, P., Triaryl pyrazoline compound inhibits flavivirus RNA replication. Antimicrob Agents Chemother 2006, 50, 1320-1329.
http://dx.doi.org/10.1128/AAC.50.4.1320-1329.2006
Kawazura, H.; Takahashi, Y.; Shiga, Y.; Shimada, F.; Ohto, N.; Tamura, A., Cerebroprotective effects of a novel pyrazoline derivative, MS-153, on focal ischemia in rats. Jpn J Pharmacol 1997, 73, 317-324.
http://dx.doi.org/10.1254/jjp.73.317
Amir, M.; Kumar, H.; Khan, S. A., Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents. Bioorg Med Chem Lett 2008, 18, 918-922.
http://dx.doi.org/10.1016/j.bmcl.2007.12.043
Havrylyuk, D.; Zimenkovsky, B.; Vasylenko, O.; Zaprutko, L.; Gzella, A.; Lesyk, R., Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur J Med Chem 2009, 44, 1396-1404.
http://dx.doi.org/10.1016/j.ejmech.2008.09.032
Stirrett, K. L.; Ferreras, J. A.; Jayaprakash, V.; Sinha, B. N.; Ren, T.; Quadri, L. E., Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis. Bioorg Med Chem Lett 2008, 18, 2662-2668.
http://dx.doi.org/10.1016/j.bmcl.2008.03.025
zdemir, Z.; Kandilci, H. B.; Gm?el, B.; al??, .; Bilgin, A. A., Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives. Eur J Med Chem 2007, 42, 373-379.
http://dx.doi.org/10.1016/j.ejmech.2006.09.006
Marella, A.; Ali, R.; Alam, T.; Saha, R.; Tanwar, O.; Akhter, M.; Shaquiquzzaman, M.; Mumtaz Alam, M., Pyrazolines: a biological review. Mini Rev Med Chem 2013, 13, 921-931.
http://dx.doi.org/10.2174/1389557511313060012
Jayaprakash, V.; Sinha, B. N.; Ucar, G.; Ercan, A., Pyrazoline-based mycobactin analogues as MAO-inhibitors. Bioorg Med Chem Lett 2008, 18, 6362-6368.
http://dx.doi.org/10.1016/j.bmcl.2008.10.084
Karuppasamy, M.; Mahapatra, M.; Yabanoglu, S.; Ucar, G.; Sinha, B. N.; Basu, A.; Mishra, N.; Sharon, A.; Kulandaivelu, U.; Jayaprakash, V., Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies. Bioorg Med Chem 2010, 18, 1875-1881.
http://dx.doi.org/10.1016/j.bmc.2010.01.043
Sahoo, A.; Yabanoglu, S.; Sinha, B. N.; Ucar, G.; Basu, A.; Jayaprakash, V., Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies. Bioorg Med Chem Lett 2010, 20, 132-136.
http://dx.doi.org/10.1016/j.bmcl.2009.11.015
Mishra, N.; Sasmal, D., Development of selective and reversible pyrazoline based MAO-B inhibitors: virtual screening, synthesis and biological evaluation. Bioorg Med Chem Lett 2011, 21, 1969-1973.
http://dx.doi.org/10.1016/j.bmcl.2011.02.030
Vishnu Nayak, B.; Ciftci-Yabanoglu, S.; Jadav, S. S.; Jagrat, M.; Sinha, B. N.; Ucar, G.; Jayaprakash, V., Monoamine oxidase inhibitory activity of 3, 5-biaryl-4, 5-dihydro-1H-pyrazole-1-carboxylate derivatives. Eur J of Med Chem 2013, 69, 762-767.
http://dx.doi.org/10.1016/j.ejmech.2013.09.010
Sicker, D.; Rabe, A.; Zakrzewski, A.; Mann, G., Synthesis Of Substituted N-Hydroxylactams, Lactams, Quinoline-N-Oxides, And Quinolines By Catalyzed Reductive Cyclization Of 2-Nitrocinnamoyl Derivatives With Hydrogen Platinum Black. J Prak Chem 1987, 329, 1063-1070.
http://dx.doi.org/10.1002/prac.19873290617
Matharu, B.; Sharma, J.; Manrao, M., Synthesis and antifungal potential of 2-chlorobenzal derivatives. Pestic Res J 2006, 18, 113-115.
Elkasaby, M., Michael Condensation Of Ethyl Alpha-Acetylcinnamates With Diethyl Malonate, Deoxybenzoin, Ethyl Phenylacetate, Benzyl Cyanide And Malononitrile. Indian J Chem 1976, B14, 739-741.
Zuo, B.; Wang, Q.; Wang, Y.; Ma, Y., Knoevenagel condensation over acidic zeolite. Chinese J Catal 2002, 23, 555-558.
Poindexter, G. S. 1,4-Dihydropyridine-3,5-dicarboxylates incorporating an alkyleneaminoalkylene-heteroatom moiety, procedure for their preparation, pharmaceutical compositions containing them, and their use as cardiovascular agents. EP247345A2, 1987.
Holt, A.; Sharman, D. F.; Baker, G. B.; Palcic, M. M., A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem 1997, 244, 384-392.
http://dx.doi.org/10.1006/abio.1996.9911
Stanchev, S.; Momekov, G.; Jensen, F.; Manolov, I., Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives. Eur J Med Chem 2008, 43, 694-706.
http://dx.doi.org/10.1016/j.ejmech.2007.05.005
El-Kasaby, M. A.; Salim, M. A. I., Some reactions with ethyl ?-acetylcinnamates. Egypt J Chem 1981, 23, 323-36.
De Colibus, L.; Li, M.; Binda, C.; Lustig, A.; Edmondson, D. E.; Mattevi, A., Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci 2005, 102, 12684-12689.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.